Antibiotic Prescribing in Dutch Daytime and Out-of-Hours General Practice during the COVID-19 Pandemic: A Retrospective Database Study.
COVID-19
antibiotics
antimicrobial resistance
general practice
out-of-hours
restrictions
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
25 Feb 2022
25 Feb 2022
Historique:
received:
28
01
2022
revised:
18
02
2022
accepted:
23
02
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
COVID-19 restrictions have resulted in major changes in healthcare, including the prescribing of antibiotics. We aimed to monitor antibiotic prescribing trends during the COVID-19 pandemic in Dutch general practice, both during daytime and out-of-hours (OOH). Routine care data were used from 379 daytime general practices (DGP) and 28 OOH-services over the period 2019-2021. Per week, we analyzed prescription rates per 100,000 inhabitants, overall, for respiratory and urinary tract infections (RTIs and UTIs) specifically and within age categories. We assessed changes in antibiotic prescribing during different phases of the pandemic using interrupted time series analyses. Both at DGPs and OOH-services significantly fewer antibiotics were prescribed during the COVID-19 pandemic after government measures became effective. Furthermore, the number of contacts decreased in both settings. When restrictions were revoked in 2021 prescription rates increased both at DGP and OOH-services, returning to pre-pandemic levels at OOH-services, but not in DGP. Changes in antibiotic prescribing rates were prominent for RTIs and among children up to 11 years old, but not for UTIs. To conclude, while antibiotic prescribing decreased during the first year of the COVID-19 pandemic both in daytime and out-of-hours, the pandemic does not seem to have a lasting effect on antibiotic prescribing.
Identifiants
pubmed: 35326772
pii: antibiotics11030309
doi: 10.3390/antibiotics11030309
pmc: PMC8944515
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministry of Health, Welfare and Sports, the Netherlands
ID : NA
Références
BJGP Open. 2020 Aug 25;4(3):
pubmed: 32487520
Euro Surveill. 2021 Jul;26(29):
pubmed: 34296672
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211003687
pubmed: 33733905
Arch Dis Child. 2022 Mar;107(3):e7
pubmed: 34433552
Euro Surveill. 2021 Jul;26(29):
pubmed: 34296678
Euro Surveill. 2021 Nov;26(46):
pubmed: 34794534
JAC Antimicrob Resist. 2020 Dec 08;2(4):dlaa105
pubmed: 34192254
J Med Internet Res. 2020 Nov 9;22(11):e23482
pubmed: 33031045
N Z Med J. 2020 Apr 24;133(1513):8-10
pubmed: 32325463
Lancet. 2021 Mar 20;397(10279):1063-1074
pubmed: 33676597
Br J Gen Pract. 2021 Apr 29;71(706):e331-e338
pubmed: 33690150
J Antimicrob Chemother. 2020 Jul 1;75(7):1681-1684
pubmed: 32433765
Antibiotics (Basel). 2021 Dec 04;10(12):
pubmed: 34943701
PLoS One. 2020 Aug 13;15(8):e0237629
pubmed: 32790804
Antibiotics (Basel). 2021 Feb 18;10(2):
pubmed: 33670657
J Am Med Inform Assoc. 2020 Jul 1;27(7):1132-1135
pubmed: 32324855
Lancet Respir Med. 2021 Sep;9(9):1010-1020
pubmed: 34329624
Lancet Infect Dis. 2021 Jun;21(6):e144
pubmed: 33275941
Br J Clin Pharmacol. 2022 Mar;88(3):1143-1151
pubmed: 34405427
Antibiotics (Basel). 2021 Jan 01;10(1):
pubmed: 33401408
BMJ. 2020 Mar 25;368:m1182
pubmed: 32213507
Antibiotics (Basel). 2021 May 17;10(5):
pubmed: 34067546
J Interprof Care. 2020 Sep-Oct;34(5):672-678
pubmed: 32962462
Clin Microbiol Infect. 2021 Feb 16;:
pubmed: 33601010
Scand J Prim Health Care. 2016 Dec;34(4):453-458
pubmed: 27804314
JAC Antimicrob Resist. 2020 Sep;2(3):dlaa051
pubmed: 34192249
BMJ. 2020 May 4;369:m1628
pubmed: 32366507
Br J Gen Pract. 2019 Feb;69(679):54-55
pubmed: 30704991